GSK alleges patent infringement by Moderna in development of COVID19, RSV vaccines, files lawsuit MD Bureau16 Oct 2024 3:51 PM ISTLondon: British drugmaker GlaxoSmithKline (GSK) sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of violating...
Moderna lays out plan to slice research and development spending MD Bureau Team15 Sept 2024 10:45 AM ISTWashington: Shares of Moderna tumbled after the vaccine developer said it was cutting research and development spending and pushed back its time...
Moderna forecasts lower sales next year, shares near four-year low MD Bureau Team14 Sept 2024 11:34 AM ISTLondon: Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key products and predicted...
FDA authorizes Novavax's updated COVID vaccine targeting JN.1 strain MD Bureau Team1 Sept 2024 10:45 AM ISTBengaluru: The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID...
FDA approves season's updated mRNA COVID vaccines for protection against current variants Dr. Kamal Kant Kohli24 Aug 2024 9:45 AM ISTThe U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to...
London HC decision fuels continued legal battle between Pfizer, Moderna over COVID vaccine patents Ruchika Sharma4 July 2024 4:10 PM ISTLondon: Pfizer and Moderna's legal dispute over their competing COVID-19 vaccines is poised to persist following a mixed ruling from London's...
Moderna files FDA application for JN.1 targeting COVID vaccine Ruchika Sharma11 Jun 2024 10:30 AM ISTCambridge: Moderna, Inc. has announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its...
Moderna gets USFDA nod for mRNA RSV vaccine Ruchika Sharma2 Jun 2024 1:30 PM ISTCambridge: Moderna, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), an mRNA respiratory...
COVID vaccine: Moderna wins patent case in Europe against Pfizer, BioNTech Ruchika Sharma19 May 2024 1:00 PM ISTLondon: Moderna announced on Friday that it has emerged victorious in a case at the European Patent Office against Pfizer and BioNTech concerning...
Viatris names Corinne Le Goff as Chief Commercial Officer Ruchika Sharma16 April 2024 12:30 PM ISTPittsburgh: Viatris Inc., a global healthcare company, has announced that Corinne Le Goff has joined the company as Chief Commercial Officer...
Bayer Healthcare backed Metagenomi cuts US IPO valuation target to USD 563 million Ruchika Sharma11 Feb 2024 1:30 PM ISTNew Delhi: Genetic medicines company Metagenomi Technologies said on Thursday it is aiming for a valuation of $563 million in its U.S. initial...
Moderna jumps on Oppenheimer upgrade, 2025 sales growth goal Ruchika Sharma3 Jan 2024 9:00 AM ISTAccording to Oppenheimer, Moderna could have five products on the market by 2026.
